Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma. - Wikidata - wikimedia - TriplyDB

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

http://www.wikidata.org/entity/Q39749283

about

Gene expression regulation by upstream open reading frames and human disease Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk.A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.Molecular analysis of PRRT2 gene in a case of paroxysmal kinesigenic dyskinesia patient The evolving role of radiation therapy in the management of malignant melanoma Re-annotation of presumed noncoding disease/trait-associated genetic variants by integrative analyses Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule Regulation of human PTCH1b expression by different 5' untranslated region cis-regulatory elements.Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.Interpreting noncoding genetic variation in complex traits and human disease.The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding.The genomic landscape of cutaneous melanoma.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.p53-directed translational control can shape and expand the universe of p53 target genes.The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma.Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients.Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development.TFIIA transcriptional activity is controlled by a 'cleave-and-run' Exportin-1/Taspase 1-switch.Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population.Translation acrobatics: how cancer cells exploit alternate modes of translational initiation Overlapping open reading frames strongly reduce human and yeast STN1 gene expression and affect telomere function

P2860

Q27693182-699278DD-6CB6-4025-99B3-98D186208B66 Q33986568-B01F254F-2BE2-42D2-8B5A-83CEAC583B7E Q34521706-CD985F19-39E2-49B0-9E97-1C7C89830A19 Q34606907-A91F4121-7420-4CC3-92D0-915AA82EEB5B Q35056773-7562399F-729F-4BFE-ACEF-95FDF2B4AA68 Q35227288-95F43DCC-FD8C-45F1-844E-215FF46DB705 Q35577168-2F0520AA-AE99-49E7-8188-F4CC257E136F Q35886639-D640EB0E-3260-49D0-9DB9-072E511F7A4B Q36189626-5152858D-051A-4DF0-BD34-8AECFD9D6699 Q36265691-E0D3984A-5931-479B-B573-08DB142A928F Q36988784-9FE286E3-DCA0-4523-96B6-BCFDF7E08C93 Q38261739-66F63FA8-416A-4E86-A591-0D7DCC8F679A Q38718904-FD450D1C-64C2-4878-A67A-7D044A394F39 Q38838144-0C918621-A451-4C5D-9A83-96B910D7008A Q38985225-CCD90229-A25A-4891-884C-9AC9BBA29509 Q41115366-F3DB381F-2290-4373-9000-0B4F60407983 Q41827249-861A9832-8E02-45CF-8F47-8995E096F16F Q47104868-432A8D3B-AB6E-4982-818B-ACB03A0DC05C Q47677143-CCD652B5-2F9E-4D20-8B1D-A67F4BBFC90C Q55261258-61CDBDCD-4E99-4740-9481-BB11CB91F926 Q58374805-3C773C63-AA2F-43A2-A0C6-15B8A9D49780 Q58806002-B80F7ED7-A5A7-4D5A-8BF8-7CA0AE3DF175

P2860

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

http://www.wikidata.org/entity/Q39749283

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@en

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@nl

type

label

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@en

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@nl

prefLabel

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@en

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@nl

P1433

Q39749283-C85C33E5-9086-452A-AD89-91351C5237F0

P1476

Q39749283-543D3D52-72EF-43C5-9E50-A68F03792245

P2093

Q39749283-02D2B422-F990-445B-83BB-5063405E9591

Q39749283-31EEC986-E90E-470F-B58D-C415DFE56F9E

Q39749283-34794707-E402-4E69-9001-A8150EFC3D75

Q39749283-3C7B0915-4C80-4199-B7D8-014FB46751AD

Q39749283-61AAED67-95D2-4080-8325-B2E61C043CD5

Q39749283-7BFB79A1-6DE4-47A2-8DB7-1D2F3E8FBBC1

Q39749283-91E19CE2-5CA2-495D-9948-85B0DEEA9855

Q39749283-DE011C0C-8EA2-4127-A891-AE3CC30AB534

Q39749283-DE0BFF8A-9971-470F-B888-4ADA0D8DF9C3

Q39749283-EE2F6D2B-C75B-449A-9BA8-046DF3FBC505

P2860

Q39749283-0BC82503-4BFB-4A7C-9DB2-C09BDEBAB8AD

Q39749283-0D2892C7-5718-477F-BF75-0D2914DF9DFB

Q39749283-1288E6EA-B984-4784-B8D3-764CF64554D4

Q39749283-1D9914B8-F7E1-4D53-A10F-0314F96EE90D

Q39749283-21B30085-20B1-4795-A296-6C14FB015A86

Q39749283-298AB94D-8052-45CA-AA6B-D93996FCE83E

Q39749283-2ACCD1BC-66AA-41B2-A2F4-AB805BC5472A

Q39749283-383AFC9A-B61C-46B4-99B3-107E5FEF1492

Q39749283-3BEFCD07-28B2-4264-BA31-6FDB2D99C1F3

Q39749283-489D65F9-DC29-4634-9EF5-741777F4E670

P304

Q39749283-096DD310-871C-423A-A5F7-C74AA87D71A1

P31

Q39749283-458B3284-96A7-4D6F-9B79-D3C9D5BEFB17

P356

Q39749283-D169945B-9353-4E91-8211-571E0AFDB202

P433

Q39749283-0F3BDC4E-C58A-4E52-A9CF-ED2AB5840AD2

P478

Q39749283-22AEF9E7-4B93-4D15-BF8F-6CEA2B43C717

P50

Q39749283-6B749E4B-AD12-4235-B093-AC88806ADA6C

P577

Q39749283-A9A566EB-6997-4D6F-B8F6-0C1F32967F93

P5875

Q39749283-3E210B6C-0E8A-4374-87F4-9DCA9EEFAB7D

P698

Q39749283-9F9B8280-11DE-4E5B-9345-ED5778F33F3F

P356

P1433

Human Molecular Genetics

P1476

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

@en

P2093

Alberto Inga

http://www.w3.org/2001/XMLSchema#string

Alessandra Bisio

http://www.w3.org/2001/XMLSchema#string

Alessandro Provenzani

http://www.w3.org/2001/XMLSchema#string

Alessandro Quattrone

http://www.w3.org/2001/XMLSchema#string

Giovanna Bianchi-Scarrà

http://www.w3.org/2001/XMLSchema#string

Jennifer J Jordan

http://www.w3.org/2001/XMLSchema#string

Lorenza Pastorino

http://www.w3.org/2001/XMLSchema#string

Paola Ghiorzo

http://www.w3.org/2001/XMLSchema#string

Paola Queirolo

http://www.w3.org/2001/XMLSchema#string

Sabina Nasti

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.

Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans

Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Cancer cell cycles

A global map of p53 transcription-factor binding sites in the human genome

A translational profiling approach for the molecular characterization of CNS cell types

Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.

P304

1479-1491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDQ022

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Giovanna Bianchi-Scarrà

P577

2010-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41111405

http://www.w3.org/2001/XMLSchema#string

P698

20093296

http://www.w3.org/2001/XMLSchema#string